Astellas Pharma Inc
Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.
-
New drug targets common cancer mutation in first human trial
Disease control OngoingThis early-stage study tests a new drug, ASP4396, in adults with advanced solid tumors that have a specific change in the KRAS gene (G12D). The main goals are to find a safe dose and check for side effects. Participants receive the drug through a vein and are closely monitored fo…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated May 26, 2026 11:24 UTC
-
New targeted therapy shows promise in beating back aggressive leukemia
Disease control OngoingThis study tested a new drug, ASP2215, against standard chemotherapy in 276 adults with a specific type of acute myeloid leukemia (AML) that has a FLT3 mutation and has come back or not responded to initial treatment. The goal was to see if ASP2215 helps people live longer and ke…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated May 22, 2026 13:51 UTC